nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2C9—brain cancer	0.613	1	CbGaD
Modafinil—CYP1A2—Carmustine—brain cancer	0.0697	0.308	CbGbCtD
Modafinil—CYP3A4—Temozolomide—brain cancer	0.0527	0.233	CbGbCtD
Modafinil—CYP3A4—Lomustine—brain cancer	0.0448	0.198	CbGbCtD
Modafinil—CYP3A5—Etoposide—brain cancer	0.0278	0.123	CbGbCtD
Modafinil—CYP1A2—Etoposide—brain cancer	0.0207	0.0912	CbGbCtD
Modafinil—CYP3A4—Etoposide—brain cancer	0.0108	0.0478	CbGbCtD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—OTX2—brain cancer	0.0017	0.0598	CbGpPWpGaD
Modafinil—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00131	0.046	CbGpPWpGaD
Modafinil—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00127	0.0449	CbGpPWpGaD
Modafinil—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00116	0.0408	CbGpPWpGaD
Modafinil—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000993	0.035	CbGpPWpGaD
Modafinil—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000988	0.0348	CbGpPWpGaD
Modafinil—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000904	0.0318	CbGpPWpGaD
Modafinil—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.00081	0.0285	CbGpPWpGaD
Modafinil—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000792	0.0279	CbGpPWpGaD
Modafinil—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000762	0.0268	CbGpPWpGaD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—GLI2—brain cancer	0.000739	0.026	CbGpPWpGaD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—GLI1—brain cancer	0.000695	0.0245	CbGpPWpGaD
Modafinil—Fosphenytoin—CYP2C9—brain cancer	0.000655	0.131	CrCbGaD
Modafinil—Oxaprozin—CYP2C9—brain cancer	0.00063	0.126	CrCbGaD
Modafinil—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000612	0.0216	CbGpPWpGaD
Modafinil—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000589	0.0207	CbGpPWpGaD
Modafinil—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000556	0.0196	CbGpPWpGaD
Modafinil—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000544	0.0191	CbGpPWpGaD
Modafinil—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00053	0.0187	CbGpPWpGaD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—SHH—brain cancer	0.000502	0.0177	CbGpPWpGaD
Modafinil—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000477	0.0168	CbGpPWpGaD
Modafinil—Cyclizine—CYP2C9—brain cancer	0.000462	0.0927	CrCbGaD
Modafinil—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000459	0.0161	CbGpPWpGaD
Modafinil—Phenprocoumon—CYP2C9—brain cancer	0.000449	0.09	CrCbGaD
Modafinil—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00042	0.0148	CbGpPWpGaD
Modafinil—Phenylbutazone—CYP2C9—brain cancer	0.000416	0.0835	CrCbGaD
Modafinil—ADRA1B—AMPK Signaling—STRADA—brain cancer	0.00041	0.0144	CbGpPWpGaD
Modafinil—Warfarin—CYP2C9—brain cancer	0.000398	0.0798	CrCbGaD
Modafinil—Hyperglycaemia—Carmustine—brain cancer	0.000381	0.003	CcSEcCtD
Modafinil—Angiopathy—Hydroxyurea—brain cancer	0.00038	0.00299	CcSEcCtD
Modafinil—Pneumonia—Carmustine—brain cancer	0.000379	0.00299	CcSEcCtD
Modafinil—Shock—Procarbazine—brain cancer	0.000378	0.00298	CcSEcCtD
Modafinil—Pollakiuria—Temozolomide—brain cancer	0.000377	0.00297	CcSEcCtD
Modafinil—Erectile dysfunction—Temozolomide—brain cancer	0.000376	0.00296	CcSEcCtD
Modafinil—Depression—Carmustine—brain cancer	0.000376	0.00296	CcSEcCtD
Modafinil—Chills—Hydroxyurea—brain cancer	0.000375	0.00296	CcSEcCtD
Modafinil—Tachycardia—Procarbazine—brain cancer	0.000375	0.00295	CcSEcCtD
Modafinil—Photosensitivity reaction—Temozolomide—brain cancer	0.000373	0.00294	CcSEcCtD
Modafinil—Weight increased—Temozolomide—brain cancer	0.000372	0.00293	CcSEcCtD
Modafinil—Hyperhidrosis—Procarbazine—brain cancer	0.000371	0.00293	CcSEcCtD
Modafinil—Weight decreased—Temozolomide—brain cancer	0.000369	0.00291	CcSEcCtD
Modafinil—Hyperglycaemia—Temozolomide—brain cancer	0.000368	0.0029	CcSEcCtD
Modafinil—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000368	0.013	CbGpPWpGaD
Modafinil—Stomatitis—Carmustine—brain cancer	0.000367	0.00289	CcSEcCtD
Modafinil—Urinary tract infection—Carmustine—brain cancer	0.000366	0.00289	CcSEcCtD
Modafinil—Pneumonia—Temozolomide—brain cancer	0.000366	0.00289	CcSEcCtD
Modafinil—Anorexia—Procarbazine—brain cancer	0.000366	0.00289	CcSEcCtD
Modafinil—Depression—Temozolomide—brain cancer	0.000363	0.00286	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000361	0.00285	CcSEcCtD
Modafinil—Cardiac arrest—Etoposide—brain cancer	0.00036	0.00283	CcSEcCtD
Modafinil—Nausea—Lomustine—brain cancer	0.000359	0.00283	CcSEcCtD
Modafinil—Hypotension—Procarbazine—brain cancer	0.000359	0.00283	CcSEcCtD
Modafinil—Stomatitis—Temozolomide—brain cancer	0.000355	0.0028	CcSEcCtD
Modafinil—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000354	0.0125	CbGpPWpGaD
Modafinil—Urinary tract infection—Temozolomide—brain cancer	0.000354	0.00279	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00035	0.00276	CcSEcCtD
Modafinil—Insomnia—Procarbazine—brain cancer	0.000347	0.00274	CcSEcCtD
Modafinil—Paraesthesia—Procarbazine—brain cancer	0.000345	0.00272	CcSEcCtD
Modafinil—Sinusitis—Temozolomide—brain cancer	0.000342	0.00269	CcSEcCtD
Modafinil—Somnolence—Procarbazine—brain cancer	0.000341	0.00269	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00034	0.00268	CcSEcCtD
Modafinil—Ill-defined disorder—Hydroxyurea—brain cancer	0.000338	0.00266	CcSEcCtD
Modafinil—Anaemia—Hydroxyurea—brain cancer	0.000337	0.00265	CcSEcCtD
Modafinil—Hallucination—Carmustine—brain cancer	0.000337	0.00265	CcSEcCtD
Modafinil—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000336	0.0118	CbGpPWpGaD
Modafinil—Decreased appetite—Procarbazine—brain cancer	0.000334	0.00263	CcSEcCtD
Modafinil—Oedema peripheral—Carmustine—brain cancer	0.000333	0.00263	CcSEcCtD
Modafinil—Connective tissue disorder—Carmustine—brain cancer	0.000332	0.00262	CcSEcCtD
Modafinil—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000332	0.0117	CbGpPWpGaD
Modafinil—Fatigue—Procarbazine—brain cancer	0.000331	0.00261	CcSEcCtD
Modafinil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000329	0.0116	CbGpPWpGaD
Modafinil—Malaise—Hydroxyurea—brain cancer	0.000328	0.00259	CcSEcCtD
Modafinil—Pain—Procarbazine—brain cancer	0.000328	0.00259	CcSEcCtD
Modafinil—Constipation—Procarbazine—brain cancer	0.000328	0.00259	CcSEcCtD
Modafinil—Visual impairment—Carmustine—brain cancer	0.000326	0.00257	CcSEcCtD
Modafinil—Hallucination—Temozolomide—brain cancer	0.000325	0.00256	CcSEcCtD
Modafinil—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000325	0.0114	CbGpPWpGaD
Modafinil—Pharyngitis—Temozolomide—brain cancer	0.000324	0.00256	CcSEcCtD
Modafinil—Urinary tract disorder—Temozolomide—brain cancer	0.000323	0.00254	CcSEcCtD
Modafinil—Dextropropoxyphene—CYP2C9—brain cancer	0.000322	0.0646	CrCbGaD
Modafinil—Oedema peripheral—Temozolomide—brain cancer	0.000322	0.00254	CcSEcCtD
Modafinil—Connective tissue disorder—Temozolomide—brain cancer	0.000321	0.00253	CcSEcCtD
Modafinil—Urethral disorder—Temozolomide—brain cancer	0.00032	0.00253	CcSEcCtD
Modafinil—ADRA1B—G alpha (12/13) signalling events—ABR—brain cancer	0.00032	0.0113	CbGpPWpGaD
Modafinil—Feeling abnormal—Procarbazine—brain cancer	0.000317	0.00249	CcSEcCtD
Modafinil—Convulsion—Hydroxyurea—brain cancer	0.000316	0.00249	CcSEcCtD
Modafinil—Cinnarizine—CYP2C9—brain cancer	0.000315	0.0633	CrCbGaD
Modafinil—Visual impairment—Temozolomide—brain cancer	0.000315	0.00248	CcSEcCtD
Modafinil—Gastrointestinal pain—Procarbazine—brain cancer	0.000314	0.00248	CcSEcCtD
Modafinil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000312	0.011	CbGpPWpGaD
Modafinil—Pancytopenia—Etoposide—brain cancer	0.00031	0.00245	CcSEcCtD
Modafinil—Erythema multiforme—Temozolomide—brain cancer	0.000309	0.00244	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000308	0.00243	CcSEcCtD
Modafinil—Ketoprofen—CYP2C9—brain cancer	0.000307	0.0616	CrCbGaD
Modafinil—Discomfort—Hydroxyurea—brain cancer	0.000306	0.00241	CcSEcCtD
Modafinil—Urticaria—Procarbazine—brain cancer	0.000305	0.0024	CcSEcCtD
Modafinil—Abdominal pain—Procarbazine—brain cancer	0.000304	0.00239	CcSEcCtD
Modafinil—Body temperature increased—Procarbazine—brain cancer	0.000304	0.00239	CcSEcCtD
Modafinil—Cardiac disorder—Temozolomide—brain cancer	0.000303	0.00239	CcSEcCtD
Modafinil—Arrhythmia—Carmustine—brain cancer	0.000302	0.00238	CcSEcCtD
Modafinil—Carbamazepine—CYP2C9—brain cancer	0.000297	0.0597	CrCbGaD
Modafinil—Oedema—Hydroxyurea—brain cancer	0.000297	0.00234	CcSEcCtD
Modafinil—Angiopathy—Temozolomide—brain cancer	0.000297	0.00234	CcSEcCtD
Modafinil—Mental disorder—Carmustine—brain cancer	0.000296	0.00234	CcSEcCtD
Modafinil—Infection—Hydroxyurea—brain cancer	0.000295	0.00233	CcSEcCtD
Modafinil—Immune system disorder—Temozolomide—brain cancer	0.000295	0.00233	CcSEcCtD
Modafinil—Mediastinal disorder—Temozolomide—brain cancer	0.000295	0.00232	CcSEcCtD
Modafinil—Malnutrition—Carmustine—brain cancer	0.000294	0.00232	CcSEcCtD
Modafinil—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000294	0.0104	CbGpPWpGaD
Modafinil—Chills—Temozolomide—brain cancer	0.000293	0.00231	CcSEcCtD
Modafinil—Pneumonia—Etoposide—brain cancer	0.000293	0.00231	CcSEcCtD
Modafinil—Nervous system disorder—Hydroxyurea—brain cancer	0.000292	0.0023	CcSEcCtD
Modafinil—Phenytoin—CYP2C9—brain cancer	0.000289	0.058	CrCbGaD
Modafinil—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000289	0.00228	CcSEcCtD
Modafinil—Skin disorder—Hydroxyurea—brain cancer	0.000289	0.00228	CcSEcCtD
Modafinil—Mental disorder—Temozolomide—brain cancer	0.000286	0.00226	CcSEcCtD
Modafinil—Back pain—Carmustine—brain cancer	0.000285	0.00224	CcSEcCtD
Modafinil—Malnutrition—Temozolomide—brain cancer	0.000285	0.00224	CcSEcCtD
Modafinil—Stomatitis—Etoposide—brain cancer	0.000284	0.00224	CcSEcCtD
Modafinil—Anorexia—Hydroxyurea—brain cancer	0.000283	0.00223	CcSEcCtD
Modafinil—Hypersensitivity—Procarbazine—brain cancer	0.000283	0.00223	CcSEcCtD
Modafinil—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000279	0.00983	CbGpPWpGaD
Modafinil—Dysgeusia—Temozolomide—brain cancer	0.000279	0.0022	CcSEcCtD
Modafinil—Tremor—Carmustine—brain cancer	0.000276	0.00217	CcSEcCtD
Modafinil—Asthenia—Procarbazine—brain cancer	0.000276	0.00217	CcSEcCtD
Modafinil—Back pain—Temozolomide—brain cancer	0.000275	0.00217	CcSEcCtD
Modafinil—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000273	0.0096	CbGpPWpGaD
Modafinil—Anaemia—Carmustine—brain cancer	0.000272	0.00214	CcSEcCtD
Modafinil—Agranulocytosis—Etoposide—brain cancer	0.000272	0.00214	CcSEcCtD
Modafinil—Pruritus—Procarbazine—brain cancer	0.000272	0.00214	CcSEcCtD
Modafinil—Agitation—Carmustine—brain cancer	0.000271	0.00213	CcSEcCtD
Modafinil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000267	0.00938	CbGpPWpGaD
Modafinil—Tremor—Temozolomide—brain cancer	0.000267	0.0021	CcSEcCtD
Modafinil—Dyspnoea—Hydroxyurea—brain cancer	0.000265	0.00209	CcSEcCtD
Modafinil—SLC6A3—Parkinsons Disease Pathway—CCNE1—brain cancer	0.000265	0.00931	CbGpPWpGaD
Modafinil—Somnolence—Hydroxyurea—brain cancer	0.000264	0.00208	CcSEcCtD
Modafinil—Ill-defined disorder—Temozolomide—brain cancer	0.000264	0.00208	CcSEcCtD
Modafinil—Anaemia—Temozolomide—brain cancer	0.000263	0.00207	CcSEcCtD
Modafinil—Diarrhoea—Procarbazine—brain cancer	0.000263	0.00207	CcSEcCtD
Modafinil—Dyspepsia—Hydroxyurea—brain cancer	0.000262	0.00206	CcSEcCtD
Modafinil—Agitation—Temozolomide—brain cancer	0.000261	0.00206	CcSEcCtD
Modafinil—Angioedema—Temozolomide—brain cancer	0.00026	0.00205	CcSEcCtD
Modafinil—Decreased appetite—Hydroxyurea—brain cancer	0.000258	0.00204	CcSEcCtD
Modafinil—Urinary tract disorder—Etoposide—brain cancer	0.000258	0.00204	CcSEcCtD
Modafinil—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000257	0.00202	CcSEcCtD
Modafinil—Malaise—Temozolomide—brain cancer	0.000257	0.00202	CcSEcCtD
Modafinil—Urethral disorder—Etoposide—brain cancer	0.000256	0.00202	CcSEcCtD
Modafinil—Fatigue—Hydroxyurea—brain cancer	0.000256	0.00202	CcSEcCtD
Modafinil—Vertigo—Temozolomide—brain cancer	0.000256	0.00201	CcSEcCtD
Modafinil—Convulsion—Carmustine—brain cancer	0.000255	0.00201	CcSEcCtD
Modafinil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000254	0.00895	CbGpPWpGaD
Modafinil—Hypertension—Carmustine—brain cancer	0.000254	0.002	CcSEcCtD
Modafinil—Pain—Hydroxyurea—brain cancer	0.000254	0.002	CcSEcCtD
Modafinil—Constipation—Hydroxyurea—brain cancer	0.000254	0.002	CcSEcCtD
Modafinil—Dizziness—Procarbazine—brain cancer	0.000254	0.002	CcSEcCtD
Modafinil—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000253	0.0089	CbGpPWpGaD
Modafinil—Palpitations—Temozolomide—brain cancer	0.000251	0.00198	CcSEcCtD
Modafinil—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000251	0.00883	CbGpPWpGaD
Modafinil—Myalgia—Carmustine—brain cancer	0.000251	0.00198	CcSEcCtD
Modafinil—Chest pain—Carmustine—brain cancer	0.000251	0.00198	CcSEcCtD
Modafinil—Anxiety—Carmustine—brain cancer	0.00025	0.00197	CcSEcCtD
Modafinil—Cough—Temozolomide—brain cancer	0.000248	0.00196	CcSEcCtD
Modafinil—Erythema multiforme—Etoposide—brain cancer	0.000247	0.00195	CcSEcCtD
Modafinil—Convulsion—Temozolomide—brain cancer	0.000247	0.00194	CcSEcCtD
Modafinil—Hypertension—Temozolomide—brain cancer	0.000246	0.00194	CcSEcCtD
Modafinil—Feeling abnormal—Hydroxyurea—brain cancer	0.000245	0.00193	CcSEcCtD
Modafinil—Vomiting—Procarbazine—brain cancer	0.000244	0.00192	CcSEcCtD
Modafinil—Cardiac disorder—Etoposide—brain cancer	0.000243	0.00191	CcSEcCtD
Modafinil—Confusional state—Carmustine—brain cancer	0.000242	0.00191	CcSEcCtD
Modafinil—Myalgia—Temozolomide—brain cancer	0.000242	0.00191	CcSEcCtD
Modafinil—Arthralgia—Temozolomide—brain cancer	0.000242	0.00191	CcSEcCtD
Modafinil—Rash—Procarbazine—brain cancer	0.000242	0.00191	CcSEcCtD
Modafinil—Dermatitis—Procarbazine—brain cancer	0.000242	0.00191	CcSEcCtD
Modafinil—Anxiety—Temozolomide—brain cancer	0.000241	0.0019	CcSEcCtD
Modafinil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000241	0.00848	CbGpPWpGaD
Modafinil—Headache—Procarbazine—brain cancer	0.000241	0.0019	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000241	0.0019	CcSEcCtD
Modafinil—Oedema—Carmustine—brain cancer	0.00024	0.00189	CcSEcCtD
Modafinil—Discomfort—Temozolomide—brain cancer	0.000239	0.00189	CcSEcCtD
Modafinil—Infection—Carmustine—brain cancer	0.000239	0.00188	CcSEcCtD
Modafinil—Angiopathy—Etoposide—brain cancer	0.000237	0.00187	CcSEcCtD
Modafinil—Dry mouth—Temozolomide—brain cancer	0.000237	0.00187	CcSEcCtD
Modafinil—Immune system disorder—Etoposide—brain cancer	0.000236	0.00186	CcSEcCtD
Modafinil—Mediastinal disorder—Etoposide—brain cancer	0.000236	0.00186	CcSEcCtD
Modafinil—Body temperature increased—Hydroxyurea—brain cancer	0.000235	0.00185	CcSEcCtD
Modafinil—Chills—Etoposide—brain cancer	0.000235	0.00185	CcSEcCtD
Modafinil—Tachycardia—Carmustine—brain cancer	0.000235	0.00185	CcSEcCtD
Modafinil—Confusional state—Temozolomide—brain cancer	0.000234	0.00185	CcSEcCtD
Modafinil—Anaphylactic shock—Temozolomide—brain cancer	0.000232	0.00183	CcSEcCtD
Modafinil—Oedema—Temozolomide—brain cancer	0.000232	0.00183	CcSEcCtD
Modafinil—Infection—Temozolomide—brain cancer	0.000231	0.00182	CcSEcCtD
Modafinil—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000229	0.00807	CbGpPWpGaD
Modafinil—Anorexia—Carmustine—brain cancer	0.000229	0.00181	CcSEcCtD
Modafinil—Nausea—Procarbazine—brain cancer	0.000228	0.0018	CcSEcCtD
Modafinil—Nervous system disorder—Temozolomide—brain cancer	0.000228	0.00179	CcSEcCtD
Modafinil—Diphenhydramine—CYP2C9—brain cancer	0.000226	0.0454	CrCbGaD
Modafinil—Skin disorder—Temozolomide—brain cancer	0.000226	0.00178	CcSEcCtD
Modafinil—Hypotension—Carmustine—brain cancer	0.000225	0.00177	CcSEcCtD
Modafinil—Hyperhidrosis—Temozolomide—brain cancer	0.000224	0.00177	CcSEcCtD
Modafinil—Dysgeusia—Etoposide—brain cancer	0.000223	0.00176	CcSEcCtD
Modafinil—Anorexia—Temozolomide—brain cancer	0.000221	0.00174	CcSEcCtD
Modafinil—Back pain—Etoposide—brain cancer	0.00022	0.00174	CcSEcCtD
Modafinil—Hypersensitivity—Hydroxyurea—brain cancer	0.000219	0.00173	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Carmustine—brain cancer	0.000219	0.00173	CcSEcCtD
Modafinil—Muscle spasms—Etoposide—brain cancer	0.000219	0.00173	CcSEcCtD
Modafinil—Methadone—CYP2C9—brain cancer	0.000219	0.0438	CrCbGaD
Modafinil—Insomnia—Carmustine—brain cancer	0.000217	0.00171	CcSEcCtD
Modafinil—Paraesthesia—Carmustine—brain cancer	0.000216	0.0017	CcSEcCtD
Modafinil—Dyspnoea—Carmustine—brain cancer	0.000214	0.00169	CcSEcCtD
Modafinil—Somnolence—Carmustine—brain cancer	0.000214	0.00168	CcSEcCtD
Modafinil—Asthenia—Hydroxyurea—brain cancer	0.000213	0.00168	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000212	0.00167	CcSEcCtD
Modafinil—Ill-defined disorder—Etoposide—brain cancer	0.000211	0.00167	CcSEcCtD
Modafinil—Anaemia—Etoposide—brain cancer	0.00021	0.00166	CcSEcCtD
Modafinil—Insomnia—Temozolomide—brain cancer	0.00021	0.00166	CcSEcCtD
Modafinil—Decreased appetite—Carmustine—brain cancer	0.000209	0.00165	CcSEcCtD
Modafinil—Paraesthesia—Temozolomide—brain cancer	0.000209	0.00164	CcSEcCtD
Modafinil—Gastrointestinal disorder—Carmustine—brain cancer	0.000207	0.00164	CcSEcCtD
Modafinil—Dyspnoea—Temozolomide—brain cancer	0.000207	0.00163	CcSEcCtD
Modafinil—Somnolence—Temozolomide—brain cancer	0.000206	0.00163	CcSEcCtD
Modafinil—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000206	0.00725	CbGpPWpGaD
Modafinil—Pain—Carmustine—brain cancer	0.000205	0.00162	CcSEcCtD
Modafinil—Constipation—Carmustine—brain cancer	0.000205	0.00162	CcSEcCtD
Modafinil—Malaise—Etoposide—brain cancer	0.000205	0.00162	CcSEcCtD
Modafinil—Vertigo—Etoposide—brain cancer	0.000205	0.00161	CcSEcCtD
Modafinil—Dyspepsia—Temozolomide—brain cancer	0.000204	0.00161	CcSEcCtD
Modafinil—Diarrhoea—Hydroxyurea—brain cancer	0.000203	0.0016	CcSEcCtD
Modafinil—Decreased appetite—Temozolomide—brain cancer	0.000202	0.00159	CcSEcCtD
Modafinil—Gastrointestinal disorder—Temozolomide—brain cancer	0.0002	0.00158	CcSEcCtD
Modafinil—Fatigue—Temozolomide—brain cancer	0.0002	0.00158	CcSEcCtD
Modafinil—Loss of consciousness—Etoposide—brain cancer	0.0002	0.00158	CcSEcCtD
Modafinil—Cough—Etoposide—brain cancer	0.000199	0.00157	CcSEcCtD
Modafinil—Pain—Temozolomide—brain cancer	0.000199	0.00157	CcSEcCtD
Modafinil—Constipation—Temozolomide—brain cancer	0.000199	0.00157	CcSEcCtD
Modafinil—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000198	0.00697	CbGpPWpGaD
Modafinil—Feeling abnormal—Carmustine—brain cancer	0.000198	0.00156	CcSEcCtD
Modafinil—Convulsion—Etoposide—brain cancer	0.000197	0.00155	CcSEcCtD
Modafinil—Hypertension—Etoposide—brain cancer	0.000197	0.00155	CcSEcCtD
Modafinil—Dizziness—Hydroxyurea—brain cancer	0.000197	0.00155	CcSEcCtD
Modafinil—Gastrointestinal pain—Carmustine—brain cancer	0.000197	0.00155	CcSEcCtD
Modafinil—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000196	0.00688	CbGpPWpGaD
Modafinil—Chest pain—Etoposide—brain cancer	0.000194	0.00153	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000193	0.00152	CcSEcCtD
Modafinil—Discomfort—Etoposide—brain cancer	0.000192	0.00151	CcSEcCtD
Modafinil—Feeling abnormal—Temozolomide—brain cancer	0.000191	0.00151	CcSEcCtD
Modafinil—Abdominal pain—Carmustine—brain cancer	0.00019	0.0015	CcSEcCtD
Modafinil—Body temperature increased—Carmustine—brain cancer	0.00019	0.0015	CcSEcCtD
Modafinil—Gastrointestinal pain—Temozolomide—brain cancer	0.00019	0.0015	CcSEcCtD
Modafinil—Vomiting—Hydroxyurea—brain cancer	0.000189	0.00149	CcSEcCtD
Modafinil—Rash—Hydroxyurea—brain cancer	0.000187	0.00148	CcSEcCtD
Modafinil—Confusional state—Etoposide—brain cancer	0.000187	0.00148	CcSEcCtD
Modafinil—Dermatitis—Hydroxyurea—brain cancer	0.000187	0.00148	CcSEcCtD
Modafinil—Headache—Hydroxyurea—brain cancer	0.000186	0.00147	CcSEcCtD
Modafinil—Anaphylactic shock—Etoposide—brain cancer	0.000186	0.00146	CcSEcCtD
Modafinil—Infection—Etoposide—brain cancer	0.000185	0.00146	CcSEcCtD
Modafinil—Urticaria—Temozolomide—brain cancer	0.000184	0.00145	CcSEcCtD
Modafinil—Abdominal pain—Temozolomide—brain cancer	0.000184	0.00145	CcSEcCtD
Modafinil—Body temperature increased—Temozolomide—brain cancer	0.000184	0.00145	CcSEcCtD
Modafinil—Tachycardia—Etoposide—brain cancer	0.000181	0.00143	CcSEcCtD
Modafinil—Skin disorder—Etoposide—brain cancer	0.00018	0.00142	CcSEcCtD
Modafinil—Hyperhidrosis—Etoposide—brain cancer	0.00018	0.00142	CcSEcCtD
Modafinil—Anorexia—Etoposide—brain cancer	0.000177	0.0014	CcSEcCtD
Modafinil—Hypersensitivity—Carmustine—brain cancer	0.000177	0.0014	CcSEcCtD
Modafinil—Nausea—Hydroxyurea—brain cancer	0.000177	0.00139	CcSEcCtD
Modafinil—Hypotension—Etoposide—brain cancer	0.000174	0.00137	CcSEcCtD
Modafinil—Asthenia—Carmustine—brain cancer	0.000172	0.00136	CcSEcCtD
Modafinil—Hypersensitivity—Temozolomide—brain cancer	0.000171	0.00135	CcSEcCtD
Modafinil—Paraesthesia—Etoposide—brain cancer	0.000167	0.00132	CcSEcCtD
Modafinil—Asthenia—Temozolomide—brain cancer	0.000167	0.00131	CcSEcCtD
Modafinil—Dyspnoea—Etoposide—brain cancer	0.000166	0.00131	CcSEcCtD
Modafinil—Somnolence—Etoposide—brain cancer	0.000165	0.0013	CcSEcCtD
Modafinil—Diarrhoea—Carmustine—brain cancer	0.000164	0.0013	CcSEcCtD
Modafinil—Pruritus—Temozolomide—brain cancer	0.000164	0.00129	CcSEcCtD
Modafinil—Decreased appetite—Etoposide—brain cancer	0.000162	0.00127	CcSEcCtD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000161	0.00565	CbGpPWpGaD
Modafinil—Gastrointestinal disorder—Etoposide—brain cancer	0.00016	0.00126	CcSEcCtD
Modafinil—Fatigue—Etoposide—brain cancer	0.00016	0.00126	CcSEcCtD
Modafinil—Dizziness—Carmustine—brain cancer	0.000159	0.00125	CcSEcCtD
Modafinil—Pain—Etoposide—brain cancer	0.000159	0.00125	CcSEcCtD
Modafinil—Constipation—Etoposide—brain cancer	0.000159	0.00125	CcSEcCtD
Modafinil—Diarrhoea—Temozolomide—brain cancer	0.000159	0.00125	CcSEcCtD
Modafinil—Dizziness—Temozolomide—brain cancer	0.000154	0.00121	CcSEcCtD
Modafinil—Feeling abnormal—Etoposide—brain cancer	0.000153	0.00121	CcSEcCtD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000153	0.00538	CbGpPWpGaD
Modafinil—Vomiting—Carmustine—brain cancer	0.000153	0.0012	CcSEcCtD
Modafinil—Gastrointestinal pain—Etoposide—brain cancer	0.000152	0.0012	CcSEcCtD
Modafinil—ADRA1B—G alpha (12/13) signalling events—VAV1—brain cancer	0.000152	0.00535	CbGpPWpGaD
Modafinil—Rash—Carmustine—brain cancer	0.000152	0.00119	CcSEcCtD
Modafinil—Dermatitis—Carmustine—brain cancer	0.000151	0.00119	CcSEcCtD
Modafinil—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000151	0.00531	CbGpPWpGaD
Modafinil—Headache—Carmustine—brain cancer	0.000151	0.00119	CcSEcCtD
Modafinil—Vomiting—Temozolomide—brain cancer	0.000148	0.00116	CcSEcCtD
Modafinil—Urticaria—Etoposide—brain cancer	0.000148	0.00116	CcSEcCtD
Modafinil—Body temperature increased—Etoposide—brain cancer	0.000147	0.00116	CcSEcCtD
Modafinil—Abdominal pain—Etoposide—brain cancer	0.000147	0.00116	CcSEcCtD
Modafinil—Rash—Temozolomide—brain cancer	0.000146	0.00115	CcSEcCtD
Modafinil—Dermatitis—Temozolomide—brain cancer	0.000146	0.00115	CcSEcCtD
Modafinil—Headache—Temozolomide—brain cancer	0.000145	0.00115	CcSEcCtD
Modafinil—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000145	0.0051	CbGpPWpGaD
Modafinil—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000143	0.00503	CbGpPWpGaD
Modafinil—Nausea—Carmustine—brain cancer	0.000143	0.00113	CcSEcCtD
Modafinil—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000142	0.00498	CbGpPWpGaD
Modafinil—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.00014	0.00492	CbGpPWpGaD
Modafinil—Nausea—Temozolomide—brain cancer	0.000138	0.00109	CcSEcCtD
Modafinil—Hypersensitivity—Etoposide—brain cancer	0.000137	0.00108	CcSEcCtD
Modafinil—SLC6A3—Dopaminergic Neurogenesis—STAT3—brain cancer	0.000136	0.0048	CbGpPWpGaD
Modafinil—Asthenia—Etoposide—brain cancer	0.000133	0.00105	CcSEcCtD
Modafinil—Pruritus—Etoposide—brain cancer	0.000131	0.00104	CcSEcCtD
Modafinil—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.00013	0.00457	CbGpPWpGaD
Modafinil—Diarrhoea—Etoposide—brain cancer	0.000127	0.001	CcSEcCtD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000124	0.00436	CbGpPWpGaD
Modafinil—Dizziness—Etoposide—brain cancer	0.000123	0.000969	CcSEcCtD
Modafinil—Vomiting—Etoposide—brain cancer	0.000118	0.000931	CcSEcCtD
Modafinil—Rash—Etoposide—brain cancer	0.000117	0.000923	CcSEcCtD
Modafinil—Dermatitis—Etoposide—brain cancer	0.000117	0.000923	CcSEcCtD
Modafinil—Headache—Etoposide—brain cancer	0.000116	0.000918	CcSEcCtD
Modafinil—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000115	0.00405	CbGpPWpGaD
Modafinil—Nausea—Etoposide—brain cancer	0.00011	0.00087	CcSEcCtD
Modafinil—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000109	0.00385	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000108	0.0038	CbGpPWpGaD
Modafinil—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000106	0.00372	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—PIK3CG—brain cancer	0.000103	0.00363	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—PTCH2—brain cancer	9.91e-05	0.00349	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—TRPC6—brain cancer	9.76e-05	0.00344	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—S100A10—brain cancer	9.47e-05	0.00333	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	8.8e-05	0.0031	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	8.73e-05	0.00307	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—OR14C36—brain cancer	8.69e-05	0.00306	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—OR4C12—brain cancer	8.69e-05	0.00306	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—RELA—brain cancer	8.56e-05	0.00301	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP2C9—brain cancer	8.53e-05	0.003	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	8.41e-05	0.00296	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—OR4C12—brain cancer	7.89e-05	0.00278	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—OR14C36—brain cancer	7.89e-05	0.00278	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.58e-05	0.00232	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.49e-05	0.00229	CbGpPWpGaD
Modafinil—ADRA1B—LPA receptor mediated events—EGFR—brain cancer	5.89e-05	0.00207	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—SHH—brain cancer	5.11e-05	0.0018	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PTCH2—brain cancer	5.09e-05	0.00179	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.08e-05	0.00179	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—PTCH1—brain cancer	4.84e-05	0.0017	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—SMO—brain cancer	4.84e-05	0.0017	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—OR14C36—brain cancer	4.66e-05	0.00164	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—OR4C12—brain cancer	4.66e-05	0.00164	CbGpPWpGaD
Modafinil—ADRA1B—AMPK Signaling—TP53—brain cancer	4.66e-05	0.00164	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.57e-05	0.00161	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—ABR—brain cancer	4.39e-05	0.00155	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—TRPC6—brain cancer	4.37e-05	0.00154	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.2e-05	0.00148	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—ABR—brain cancer	3.99e-05	0.0014	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DTX2—brain cancer	3.96e-05	0.0014	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.89e-05	0.00137	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.57e-05	0.00126	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.5e-05	0.00123	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.5e-05	0.00123	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.28e-05	0.00115	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.07e-05	0.00108	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTCH2—brain cancer	3e-05	0.00106	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HES5—brain cancer	2.91e-05	0.00102	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STRADA—brain cancer	2.82e-05	0.000994	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.8e-05	0.000987	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—TRPC6—brain cancer	2.78e-05	0.000979	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—SHH—brain cancer	2.62e-05	0.000922	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—TRPC6—brain cancer	2.53e-05	0.000889	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PTCH1—brain cancer	2.48e-05	0.000874	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—SMO—brain cancer	2.48e-05	0.000874	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2C9—brain cancer	2.48e-05	0.000872	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2C9—brain cancer	2.42e-05	0.000852	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.4e-05	0.000843	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ABR—brain cancer	2.36e-05	0.00083	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GLI2—brain cancer	2.28e-05	0.000801	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.24e-05	0.000787	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GLI1—brain cancer	2.14e-05	0.000753	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—BSG—brain cancer	2.11e-05	0.000742	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—VAV1—brain cancer	2.08e-05	0.000734	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—BSG—brain cancer	2.06e-05	0.000725	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SUFU—brain cancer	2.03e-05	0.000714	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GFAP—brain cancer	1.96e-05	0.000689	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—VAV1—brain cancer	1.89e-05	0.000666	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2C9—brain cancer	1.87e-05	0.000659	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HEY1—brain cancer	1.86e-05	0.000653	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DLL1—brain cancer	1.82e-05	0.000641	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—IDH1—brain cancer	1.81e-05	0.000638	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—IDH1—brain cancer	1.77e-05	0.000623	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—BSG—brain cancer	1.59e-05	0.00056	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SHH—brain cancer	1.55e-05	0.000545	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TRPC6—brain cancer	1.49e-05	0.000525	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SMO—brain cancer	1.47e-05	0.000516	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTCH1—brain cancer	1.47e-05	0.000516	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2C9—brain cancer	1.46e-05	0.000514	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BSG—brain cancer	1.45e-05	0.000511	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ENO2—brain cancer	1.43e-05	0.000504	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ENO2—brain cancer	1.4e-05	0.000493	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—IDH1—brain cancer	1.37e-05	0.000482	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	1.32e-05	0.000466	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—IDH1—brain cancer	1.25e-05	0.000439	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BSG—brain cancer	1.24e-05	0.000437	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	1.2e-05	0.000423	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	1.17e-05	0.000413	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2C9—brain cancer	1.13e-05	0.000396	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VAV1—brain cancer	1.12e-05	0.000394	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.11e-05	0.000392	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ENO2—brain cancer	1.08e-05	0.000381	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—IDH1—brain cancer	1.07e-05	0.000375	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.02e-05	0.000358	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ENO2—brain cancer	9.87e-06	0.000347	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HES1—brain cancer	9.62e-06	0.000338	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BSG—brain cancer	9.57e-06	0.000337	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—brain cancer	9.31e-06	0.000328	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	9.16e-06	0.000322	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SPP1—brain cancer	8.89e-06	0.000313	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.69e-06	0.000306	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—brain cancer	8.46e-06	0.000298	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ENO2—brain cancer	8.43e-06	0.000297	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—IDH1—brain cancer	8.23e-06	0.00029	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS2—brain cancer	8.04e-06	0.000283	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	7.1e-06	0.00025	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—brain cancer	7.1e-06	0.00025	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—brain cancer	6.57e-06	0.000231	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ENO2—brain cancer	6.51e-06	0.000229	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—brain cancer	6.47e-06	0.000228	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—brain cancer	6.42e-06	0.000226	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RELA—brain cancer	5.55e-06	0.000195	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—brain cancer	5.51e-06	0.000194	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—brain cancer	5e-06	0.000176	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—brain cancer	4.96e-06	0.000175	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—brain cancer	4.87e-06	0.000171	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	4.82e-06	0.00017	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—brain cancer	4.53e-06	0.000159	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—brain cancer	4.25e-06	0.000149	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—brain cancer	4.2e-06	0.000148	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—brain cancer	3.91e-06	0.000137	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—brain cancer	3.87e-06	0.000136	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.82e-06	0.000134	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—brain cancer	3.21e-06	0.000113	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—brain cancer	2.99e-06	0.000105	CbGpPWpGaD
